These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19541561)

  • 1. 2009 novel H1N1 influenza: the impact of viral genomic reassortment on immune evasion and vaccine strategy.
    Huang YH
    J Chin Med Assoc; 2009 Jun; 72(6):281-2. PubMed ID: 19541561
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
    Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
    Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
    Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
    Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.
    Sambhara V
    J Infect Dis; 2011 Jun; 203(11):1697-8. PubMed ID: 21593002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
    Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of the gene composition of influenza H5 virus hemagglutinin-containing reassortants and their efficacy in immune cross-protection experiments].
    Rudneva IA; Kaverin NV; Timofeeva TA; Shilov AA; Varich NL; Kochergin-Nikitskiĭ KS; Krylov PS; L'vov DK
    Vopr Virusol; 2008; 53(1):24-7. PubMed ID: 18318131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
    Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
    Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.
    Gomila RC; Suphaphiphat P; Judge C; Spencer T; Ferrari A; Wen Y; Palladino G; Dormitzer PR; Mason PW
    Vaccine; 2013 Oct; 31(42):4736-43. PubMed ID: 23973324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.
    Farnsworth A; Cyr TD; Li C; Wang J; Li X
    Vaccine; 2011 Feb; 29(8):1529-33. PubMed ID: 21211583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
    Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.
    Dlugolenski D; Jones L; Howerth E; Wentworth D; Tompkins SM; Tripp RA
    J Virol; 2015 May; 89(10):5651-67. PubMed ID: 25762737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
    Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
    Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.